NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action

This publication has 58 references indexed in Scilit:

• Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compound
  Bioorganic & Medicinal Chemistry, 2008
• NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min mice
  Carcinogenesis: Integrative Cancer Research, 2008
• Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
  Journal of Translational Medicine, 2007
• JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
  Blood, 2007
• The mechanism of action of nitric oxide-donating aspirin
  Biochemical and Biophysical Research Communications, 2007
• O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO–NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies
  Bioorganic & Medicinal Chemistry, 2007
• Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines*
  Apoptosis, 2006
• In Vitro Metabolism of (Nitrooxy)butyl Ester Nitric Oxide-Releasing Compounds: Comparison with Glyceryl Trinitrate
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat
  Life Sciences, 2004
• NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) mice
  Biochemical and Biophysical Research Communications, 2003